Ep188: Art Krieg on Innate Immune System Activators for Cancer
Podcast: The Long Run with Luke TimmermanPublished On: Tue Oct 28 2025
Description: Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
The note was deleted
The note was saved
Your message was sent